MedPath

Feasibility of the Gamification of Incentive Spirometry in Trauma Patients

Not Applicable
Withdrawn
Conditions
Thoracic Trauma
Interventions
Device: OmniFlow Breathing Therapy BioFeeback System
Registration Number
NCT06090279
Lead Sponsor
Wake Forest University Health Sciences
Brief Summary

Gamification may be one solution that can increase the compliance in the use of devices like incentive spirometry.

Detailed Description

Recently, there has been much interest in the gamification of healthcare, such as virtual incentive spirometry gaming. Several studies have examined the addition of gamification e.g. virtual incentive spirometry devices. There is a paucity of data regarding the gamification of incentive spirometry, and there is no data involving trauma patients. Previous studies have enrolled either healthy volunteers or patients with specific lung pathology. This study to assess the safety, feasibility and efficacy of respiratory interventions in chest trauma patients using a therapeutic gamification platform.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Patients will be included if informed consent can be obtained from patient themselves and first session of incentive spirometry gamification can be performed within 48 hours of Trauma Intensive Care Unit (TICU) admission
  • Adult patients (≥ 18 years of age) in the TICU with rib fractures or flail segment or a sternal fracture
Exclusion Criteria
  • Trauma patients in the TICU who are mechanically ventilated or requiring bilevel positive airway pressure (BiPAP)
  • Glasgow Coma Scale (GCS) < 15, at the time of enrollment
  • Facial fractures precluding the use of incentive spirometry
  • Any organ injury that precludes use of respiratory therapies in the clinical judgement of the clinical team
  • Patients who are expected to be transferred out of the TICU or discharged from the TICU in the next 24 hours based on treating physicians judgment
  • Patients who are transitioning to palliative care or expected to die in the next 48 hours based on treating physician's judgment will not be included
  • Patients unable to consent for themselves
  • Patients unable to use the mouthpiece of the Omniflow system, and those who have visual or hearing impairments that could limit their ability to evaluate the games

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
OmniFlow Breathing Therapy BioFeeback SystemOmniFlow Breathing Therapy BioFeeback SystemThis system is a FDA approved healthcare gaming system that is used for patients who have difficulty breathing and allows the patients to participate in breathing exercises for pulmonary rehab.
Primary Outcome Measures
NameTimeMethod
Number screened and eligible compared to patient that consented to projectup to 6 months

Number screened and eligible compared to patient that consented to project

Number of days spent in Intensive Care Unit (ICU)up to 6 months

Number of days spent in Intensive Care Unit (ICU)

Number of sessions attempted, completed and aborted including the time spent in successful interventionup to 6 months

Number of sessions attempted, completed and aborted including the time spent in successful intervention

Number of Subjects readmitted to the ICU for pulmonary complicationsup to 6 months

Number of Subjects readmitted to the ICU for pulmonary complications

Reasons for aborting a session related to patient factors, staffing factors, technology factorsup to 6 months

Enter the results according to the reason

The Session will be terminated if one or more of the following occurs:

* Sustained Pain Score \>8/10

* Increase in oxygen requirements by more than 2L/min or hypoxia to less than 92% during the intervention or need for escalation of an oxygen supplementation device

* Sustained Heart Rate \>110 beats per minute, new cardiac arrhythmia or respiratory rate \>30 per minute

* Cyanosis, pallor, or new onset confusion

* Refusal to continue by choice, reduced engagement in game, adverse symptoms related to dyspnea, pain or discomfort related to the intervention

* These safety measures are vital sign derangements or signs/symptoms that predict threat to the patient's health

* Sessions unable to be performed after enrollment due to lack of personnel

* Failure of intervention device to work, failure of accompanying gamification platform to work

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Wake Forest University Health Sciences

🇺🇸

Winston-Salem, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath